Home Fluorides 325-14-4
325-14-4,MFCD00833760
Catalog No.:AA003N9I

325-14-4 | 7-(Trifluoromethyl)quinoline

Pack Size
Purity
Availability
Price(USD)
Quantity
  
100mg
97%
in stock  
$9.00   $7.00
- +
1g
97%
in stock  
$70.00   $49.00
- +
5g
97%
in stock  
$334.00   $234.00
- +
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Upstream Synthesis Route
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA003N9I
Chemical Name:
7-(Trifluoromethyl)quinoline
CAS Number:
325-14-4
Molecular Formula:
C10H6F3N
Molecular Weight:
197.1565
MDL Number:
MFCD00833760
SMILES:
FC(c1ccc2c(c1)nccc2)(F)F
Properties
Properties
 
BP:
243.7±35.0°C at 760 mmHg  
Form:
Solid  
MP:
65-67 °C  
Storage:
Keep in dry area;2-8℃;  

Computed Properties
 
Complexity:
202  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
14  
Hydrogen Bond Acceptor Count:
4  
XLogP3:
3  

Upstream Synthesis Route

[1]JournaloftheAmericanChemicalSociety,1943,vol.65,p.2467

[1]Patent:US2010/234340,2010,A1,.Locationinpatent:Page/Pagecolumn21

[2]BioorganicandMedicinalChemistry,2005,vol.13,#1,p.59-68

[3]Patent:US2004/204455,2004,A1,.Locationinpatent:Page/Pagecolumn21

[4]BioorganicandMedicinalChemistryLetters,1999,vol.9,#10,p.1403-1408

[5]Patent:US2008/275037,2008,A1,.Locationinpatent:Page/Pagecolumn33

[1]SyntheticCommunications,2018,vol.48,#11,p.1291-1298

[2]Chemistry-AEuropeanJournal,2017,vol.23,#57,p.14167-14172

[3]OrganicLetters,2016,vol.18,#24,p.6300-6303

[4]Patent:CN107162968,2017,A,.Locationinpatent:Paragraph0018;0019;0020-0023;0030-0050;0103-0106

[5]AdvancedSynthesisandCatalysis,2017,vol.359,#14,p.2358-2363

[6]OrganicLetters,2018,vol.20,#20,p.6436-6439

[1]BioorganicandMedicinalChemistry,2005,vol.13,#1,p.59-68

[2]Patent:US2004/204455,2004,A1,.Locationinpatent:Page/Pagecolumn17

[3]BioorganicandMedicinalChemistryLetters,1999,vol.9,#10,p.1403-1408

[4]Patent:US2008/275037,2008,A1,.Locationinpatent:Page/Pagecolumn33

[1]Patent:CN108409649,2018,A,.Locationinpatent:Paragraph0042;0043;0044

[2]Patent:US2010/234340,2010,A1,.Locationinpatent:Page/Pagecolumn21

Downstream Synthesis Route
325-14-4    75-03-6   
1-ethyl-7-trifluoromethyl-quinolinium;iodide 

[1]Experientia,1947,vol.3,p.28

[1]JournaloftheAmericanChemicalSociety,1943,vol.65,p.2467

[1]JournaloftheAmericanChemicalSociety,1943,vol.65,p.2467

[1]JournaloftheAmericanChemicalSociety,2019,vol.141,p.20424-20433

[2]AdvancedSynthesisandCatalysis,2017,vol.359,p.677-686

[3]Patent:US2432393,1943,

[4]Patent:US2442345,1945,

[1]JournaloftheAmericanChemicalSociety,1946,vol.68,p.426

Literature

Title: In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS).

Journal: In vivo (Athens, Greece) 20010101

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:325-14-4 Molecular Formula|325-14-4 MDL|325-14-4 SMILES|325-14-4 7-(Trifluoromethyl)quinoline |Fluorinated_Building_Blocks